Protein profiling plays an essential part in today’s biomedical research, striving to improve patients’ quality of life by using molecular signatures for diagnosis and treatment guidance.
At Sciomics, we believe that our explorative proteomic and post-translational modification profiling platform enables true progress in precision medicine. Therefore, our internal development pipeline of innovative biomarker signatures for precision medicine is based on this powerful platform.
In addition, we offer services based on our scioDiscover profiling platform and R&D collaborations for the discovery and validation of novel biomarkers, for drug target screening, the characterization of disease models, and for the analysis of pathway activity as well as mode-of-action analyses. What sets us apart is our team of scientific experts that takes pride in custom-tailoring every project and consulting clients throughout the project. Our full service ranges from discussing experimental designs to in-depth data analysis and a comprehensive study report. Fast and cost-efficient, Sciomics‘ powerful high-content, high-throughput antibody array platform delivers reliable results that can be easily translated into validation or clinical assays, thereby generating value and opening new avenues for biomarker discovery as well as preclinical drug discovery & development programs.